Scot Michael Elder

This profile gathers the share dealings of Scot Michael Elder in Treace Medical Concepts, Inc., where the filings describe the role as senior executive. In total, 24 filings cover trades dated from 8 March 2022 to 30 September 2026.

On the open market, the record shows 1 purchase worth €77k and 2 sales worth €18k. Purchases outweigh sales by €59k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 21 share grants.

The record was last updated on 2 October 2026 with a share grant in Treace Medical Concepts, Inc. The most recent open-market purchase was published on 17 November 2022, 1,431 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.